Resultados da busca - Dara L. Aisner

Refinar Resultados
  1. 1
    Molecular Pathology of Non–Small Cell Lung Cancer

    Molecular Pathology of Non–Small Cell Lung Cancer por Dara L. Aisner, Carrie B. Marshall

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy

    Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy por Susan J. Hsiao, Ahmet Zehir, Anthony Sireci, Dara L. Aisner

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation

    BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation por Bette K. Kleinschmidt‐DeMasters, Dara L. Aisner, Nicholas K. Foreman

    Publicado em 2015
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Lack of cell cycle regulation of telomerase activity in human cells

    Lack of cell cycle regulation of telomerase activity in human cells por Shawn E. Holt, Dara L. Aisner, Jerry W. Shay, Woodring E. Wright

    Publicado em 1997
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation

    Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation por Bette K. Kleinschmidt‐DeMasters, Dara L. Aisner, Diane K. Birks, Nicholas K. Foreman

    Publicado em 2013
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Anaplastic PXA in adults: case series with clinicopathologic and molecular features

    Anaplastic PXA in adults: case series with clinicopathologic and molecular features por Yao Schmidt, Bette K. Kleinschmidt‐DeMasters, Dara L. Aisner, Kevin O. Lillehei, Denise Damek

    Publicado em 2012
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR- Mutant Non–Small Cell Lung Cancer

    Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR- Mutant Non–Small Cell... por Emily R. York, Marileila Varella‐Garcia, Tami J. Bang, Dara L. Aisner, D. Ross Camidge

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer

    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer por Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

    Publicado em 2012
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  9. 9
    An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity

    An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity por Xiaoming Yi, Dennis M. White, Dara L. Aisner, Joseph A. Baur, Woodring E. Wright, Jerry W. Shay

    Publicado em 2000
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    <i>PIK3CA</i>Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    <i>PIK3CA</i>Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer por Aryana R. Rasti, Amy Guimaraes-Young, Farrah Mikhail Datko, Virginia F. Borges, Dara L. Aisner, Elena Shagisultanova

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  11. 11
    Targeting the WNT Signaling Pathway in Cancer Therapeutics

    Targeting the WNT Signaling Pathway in Cancer Therapeutics por David Tai, Keith Wells, John J. Arcaroli, Chad Vanderbilt, Dara L. Aisner, Wells A. Messersmith, Christopher H. Lieu

    Publicado em 2015
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  12. 12
    DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

    DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer por Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Michael Yourshaw, Gregary T. Bocsi, D. Ross Camidge, Dara L. Aisner

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer

    Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer por Shengxiang Ren, Fred R. Hirsch, Marileila Varella‐Garcia, Dara L. Aisner, Theresa A. Boyle, Caicun Zhou, D. Ross Camidge

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer por Rafał Dziadziuszko, Anh T. Le, Anna Wrona, Jacek Jassem, D. Ross Camidge, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers por Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion

    Dramatic Response to Crizotinib in a Patient With Lung Cancer Positive for an <i>HLA-DRB1-MET</i> Gene Fusion por Kurtis D. Davies, Terry L. Ng, Adriana Estrada‐Bernal, Anh T. Le, Peter R. Ennever, D. Ross Camidge, Robert C. Doebele, Dara L. Aisner

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Two Inactive Fragments of the Integral RNA Cooperate To Assemble Active Telomerase with the Human Protein Catalytic Subunit (hTERT) In Vitro

    Two Inactive Fragments of the Integral RNA Cooperate To Assemble Active Telomerase with the Human Protein Catalytic Subunit (hTERT) In Vitro por Valerie M. Tesmer, Lance P. Ford, Shawn E. Holt, Bryan Frank, Xiaoming Yi, Dara L. Aisner, Michel Ouellette, Jerry W. Shay, Woodring E. Wright

    Publicado em 1999
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples por Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L. Jones, Marileila Varella‐Garcia, Dara L. Aisner, Robert C. Doebele

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Activation of RAS family members confers resistance to ROS1 targeting drugs

    Activation of RAS family members confers resistance to ROS1 targeting drugs por Marilisa Cargnelutti, Simona Corso, Margherita Pergolizzi, Laurence Mévellec, Dara L. Aisner, Rafał Dziadziuszko, Marileila Varella‐Garcia, Paolo M. Comoglio, Robert C. Doebele, Jorge Vialard, Silvia Giordano

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

    The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib por Tejas Patil, Derek Smith, Paul A. Bunn, Dara L. Aisner, Anh T. Le, Mark J. Hancock, W. Thomas Purcell, Daniel W. Bowles, D. Ross Camidge, Robert C. Doebele

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: